Sanofi

OTC: SNYNF

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Sanofi

Market closed

 --Quotes are delayed by 20 min

Aug 17, 2022, 3:50 p.m.

SNYNF
/zigman2/quotes/205505035/composite

$

84.25

Change

-5.26 -5.88%

Volume

Volume 5,840

Quotes are delayed by 20 min

/zigman2/quotes/205505035/composite

Previous close

$ 89.51

$ 84.25

Change

-5.26 -5.88%

Day low

Day high

$81.35

$84.35

Open

52 week low

52 week high

$81.35

$112.50

Open

Company Description

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specia...

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.

Valuation

P/E Current

17.50

P/E Ratio (with extraordinary items)

16.39

P/E Ratio (without extraordinary items)

17.83

Price to Sales Ratio

2.95

Price to Book Ratio

1.62

Price to Cash Flow Ratio

10.59

Enterprise Value to EBITDA

10.25

Enterprise Value to Sales

3.01

Total Debt to Enterprise Value

0.18

Efficiency

Revenue/Employee

395,643.00

Income Per Employee

65,202.00

Receivables Turnover

3.83

Total Asset Turnover

0.32

Liquidity

Current Ratio

1.44

Quick Ratio

1.03

Cash Ratio

0.47

Profitability

Gross Margin

63.07

Operating Margin

22.95

Pretax Margin

20.65

Net Margin

16.48

Return on Assets

5.30

Return on Equity

9.45

Return on Total Capital

9.72

Return on Invested Capital

7.26

Capital Structure

Total Debt to Total Equity

32.63

Total Debt to Total Capital

24.61

Total Debt to Total Assets

18.64

Long-Term Debt to Equity

27.61

Long-Term Debt to Total Capital

20.82

Officers and Executives

Name Age Officer Since Title
Mr. Serge Weinberg 70 2009 Director
Mr. Paul Hudson 53 2019 Chief Executive Officer
Mr. Jean-Baptiste Chasseloup de Chatillon 56 2018 Chief Financial Officer & Executive Vice President
Dr. Dietmar P. Berger - - Chief Medical Officer & Global Head-Development
Dr. John C. Reed 61 2018 EVP & Global Head-Research & Development

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
12/22/2021 Barbara Lavernos
500   Acquisition at $87.7 per share. 43,850
12/22/2021 Barbara Lavernos
500   Acquisition at $87.7 per share. 43,850
11/18/2020 Rachel Duan
601   Acquisition at $85.63 per share. 51,463
11/18/2020 Rachel Duan
132   Acquisition at $85.62 per share. 11,301
11/18/2020 Rachel Duan
267   Acquisition at $85.5 per share. 22,828
11/12/2020 Lise Kingo
1,000   Acquisition at $85.2 per share. 85,204
02/21/2020 Sanofi
96,700   Acquisition at $93.07 per share. 8,999,665
02/20/2020 Sanofi
84,000   Acquisition at $93.78 per share. 7,877,830
02/19/2020 Sanofi
60,000   Acquisition at $94.29 per share. 5,657,406
02/18/2020 Sanofi
27,700   Acquisition at $92.45 per share. 2,560,809
02/17/2020 Sanofi
27,500   Acquisition at $92.2 per share. 2,535,461
12/13/2019 Paul Hudson
5,600   Acquisition at $88.51 per share. 495,656
12/13/2019 Paul Hudson
5,600   Acquisition at $88.51 per share. 495,656
11/04/2019 Christophe Babule
500   Acquisition at $82.81 per share. 41,405
11/04/2019 Christophe Babule
500   Acquisition at $82.81 per share. 41,405
/news/latest/company/us/snynf

MarketWatch News on SNYNF

  2. video content The New Doctor in the House: Consolidation

    9:46 a.m. Feb. 1, 2011

    - Barrons.com

  3. Your Money: Pros, cons of paying taxes with a credit card

    1:14 p.m. March 14, 2000

    - CBS.MarketWatch.com

  4. Retail sales roar ahead in February

    12:48 p.m. March 14, 2000

    - CBS.MarketWatch.com

  5. Clueless Investor: Web making muni bonds more accessible to individuals

    11:55 a.m. March 14, 2000

    - CBS.MarketWatch.com

  6. World Markets: Nikkei surrenders morning session's rebound

    3:15 a.m. March 14, 2000

    - Mariko Ando

  7. Michael J. Bazdarich: No need to worry about the 'wealth effect'

    10:13 p.m. March 13, 2000

    - CBS.MarketWatch.com

  8. Washington schedule for March 13-19

    6:44 p.m. March 13, 2000

    - CBS.MarketWatch.com

  9. Joe Battipaglia: Economic data will show that inflation is tame

    12:29 p.m. March 13, 2000

    - CBS.MarketWatch.com

  10. Washington schedule for March 13-19

    1:09 p.m. March 11, 2000

    - CBS.MarketWatch.com

/news/nonmarketwatch/company/us/snynf

Other News on SNYNF

  1. Novo Nordisk: Looming Danger In An Excellent Business

    3:34 p.m. Aug. 15, 2022

    - Seeking Alpha

  2. GSK: Zantac Litigation Risks Have Been Ignored For Too Long

    1:40 p.m. Aug. 12, 2022

    - Seeking Alpha

  5. GSK, Sanofi in selloff extending Novavax-led rout

    2:14 p.m. Aug. 10, 2022

    - Seeking Alpha

  7. EWQ Has 'Made In France' Resilience On Offer

    5:54 a.m. Aug. 7, 2022

    - Seeking Alpha

  11. Sanofi: Arguably One Of The Most Undervalued Pharma Stocks

    1:31 a.m. July 29, 2022

    - Seeking Alpha

  13. Sanofi 2022 Q2 - Results - Earnings Call Presentation

    3:27 a.m. July 28, 2022

    - Seeking Alpha

  15. Seres Therapeutics: The Good And The Challenging

    1:42 p.m. July 12, 2022

    - Seeking Alpha

  17. Wide-Moat Stocks On Sale - The July 2022 Heat Map

    1:59 p.m. June 30, 2022

    - Seeking Alpha

  18. Healthcare Sector Stock Performance Continues To Improve

    7:15 a.m. June 30, 2022

    - Seeking Alpha

  21. Loading more headlines...

At a Glance

Sanofi

54, rue La Boétie

Paris, Ile-de-France 75008

Phone

33 153774000

Industry

Pharmaceuticals

Sector

Health Care/Life Sciences

Fiscal Year-end

12/2022

View SEC Filings

Revenue

$37.76B

Net Income

$6.22B

2021 Sales Growth

4.8%

Employees

95,442

Annual Report for SNYNF

/news/pressrelease/company/us/snynf

Press Releases on SNYNF

No News currently available for SNYNF

Link to MarketWatch's Slice.